EichorEICHOR
Study identifier: NCT07226232 Synced from ClinicalTrials.gov · August 04, 2026
● Not Yet Recruiting

Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression

Condition: Major Depression  ·  Sponsor: VA Office of Research and Development

PhasePhase 3
Planned participants240
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

The purpose of this multi-site randomized controlled trial is to evaluate the efficacy and risks of psilocybin for the treatment of depression in U.S. military Veterans with and without (±) concurrent posttraumatic stress disorder.

This description comes directly from the study's public registry record.

Talk to the study team

Lori L Davis, MD AB  ·  (205) 554-3819  ·  lori.davis@va.gov

Anchal Ghera, MS  ·  (205) 899-1273  ·  anchal.ghera@va.gov

Always discuss trial participation with your own doctor first.

Locations (5)

Birmingham VA Medical Center, Birmingham, ALBirmingham, Alabama, United States
Tuscaloosa VA Medical Center, Tuscaloosa, ALTuscaloosa, Alabama, United States
VA Portland Health Care System, Portland, ORPortland, Oregon, United States
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PAPhiladelphia, Pennsylvania, United States
VA Puget Sound Health Care System Seattle Division, Seattle, WASeattle, Washington, United States

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →